← Leaderboards
Michael G Brattain
University Of Texas Hlth Sci Ctr San Ant
$16,576,364
Attributed
$16,576,364
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$16,576,364 · 9
By mechanism
R01$11,939,200 · 5
R37$3,105,833 · 1
P50$1,531,331 · 3
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Autocrine”
- Peter Scott Heeger · Case Western Reserve University$29,395,562
- Joshua A Boyce · Brigham And Women'S Hospital$13,535,273
- Galen B Toews · University Of Michigan At Ann Arbor$13,322,655
- Athan Kuliopulos · Tufts Medical Center$13,308,810
- Wolfgang G Junger · University Of California San Diego$11,815,082
- E Richard Stanley · Yeshiva University$11,050,451
Research focus
AutocrineApoptosisBaseReceptor ExpressionReceptorSignal TransductionTissue /Cell CultureTransforming Growth FactorsPathway InteractionsMalignant NeoplasmsMediatingTranscription FactorGrowth Factor ReceptorsSiteNeoplasm MetastasisElementsColon CarcinomaLinkColon NeoplasmsMutationXenograft ProcedureFundingCell DeathProteins
Grant awards (67)
Novel Strategies for Pancreatic Cancer Treatment$325,621
P50 · FY2015 · CA · contact PI
Novel Strategies for Pancreatic Cancer Treatment$364,127
P50 · FY2014 · CA · contact PI
Mechanism of Action of Differentiation Agents$314,420
R01 · FY2014 · CA · contact PI
Cell Survival Determinants of Metastasis in IGF1R-Dependent CRC$232,187
R01 · FY2014 · CA · contact PI
Mechanism of Action of Differentiation Agents$304,695
R01 · FY2013 · CA · contact PI
Heterogeneity of Human Colon Carcinoma$288,034
R01 · FY2013 · CA · contact PI
Cell Survival Determinants of Metastasis in IGF1R-Dependent CRC$225,007
R01 · FY2013 · CA · contact PI
Mechanism of Action of Differentiation Agents$324,144
R01 · FY2012 · CA · contact PI
Heterogeneity of Human Colon Carcinoma$306,420
R01 · FY2012 · CA · contact PI
Cell Survival Determinants of Metastasis in IGF1R-Dependent CRC$239,369
R01 · FY2012 · CA · contact PI
Career Development Program$106,109
P50 · FY2012 · CA · contact PI
Developmental Research Program$58,510
P50 · FY2012 · CA · contact PI
Mechanism of Action of Differentiation Agents$324,144
R01 · FY2011 · CA · contact PI
Heterogeneity of Human Colon Carcinoma$306,420
R01 · FY2011 · CA · contact PI
AUTOCRINE TGF BETA AND CELL DEATH$241,433
R01 · FY2011 · CA · contact PI
Career Development Program$103,515
P50 · FY2011 · CA · contact PI
Developmental Research Program$78,515
P50 · FY2011 · CA · contact PI
Mechanism of Action of Differentiation Agents$334,170
R01 · FY2010 · CA · contact PI
Heterogeneity of Human Colon Carcinoma$315,897
R01 · FY2010 · CA · contact PI
AUTOCRINE TGF BETA AND CELL DEATH$248,900
R01 · FY2010 · CA · contact PI
Career Development Program$114,859
P50 · FY2010 · CA · contact PI
Developmental Research Program$67,077
P50 · FY2010 · CA · contact PI
Heterogeneity of Human Colon Carcinoma$315,897
R01 · FY2009 · CA · contact PI
AUTOCRINE TGF BETA AND CELL DEATH$248,900
R01 · FY2009 · CA · contact PI
Autocrine TGF alpha-Function and Control in Colon Cancer$236,951
R01 · FY2009 · CA · contact PI
Career Development Program$114,729
P50 · FY2009 · CA · contact PI
Developmental Research Program$68,728
P50 · FY2009 · CA · contact PI
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$321,158
R37 · FY2008 · CA · contact PI
AUTOCRINE TGF BETA AND CELL DEATH$248,900
R01 · FY2008 · CA · contact PI
Autocrine TGF alpha-Function and Control in Colon Cancer$181,512
R01 · FY2008 · CA · contact PI
Career Development Program$80,110
P50 · FY2008 · CA · contact PI
Developmental Research Program$49,431
P50 · FY2008 · CA · contact PI
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$321,158
R37 · FY2007 · CA · contact PI
AUTOCRINE TGF BETA AND CELL DEATH$248,900
R01 · FY2007 · CA · contact PI
Autocrine TGF alpha-Function and Control in Colon Cancer$231,731
R01 · FY2007 · CA · contact PI
Autocrine TGF alpha-Function and Control in Colon Cancer$61,293
R01 · FY2007 · CA · contact PI
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$406,339
R37 · FY2006 · CA · contact PI
HETEROGENEITY OF HUMAN COLON CARCINOMA$335,424
R01 · FY2006 · CA · contact PI
Autocrine TGF alpha-Function and Control in Colon Cancer$297,821
R01 · FY2006 · CA · contact PI
HETEROGENEITY OF HUMAN COLON CARCINOMA$11,802
R01 · FY2006 · CA · contact PI
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$422,616
R37 · FY2005 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$350,083
R01 · FY2005 · CA
Autocrine TGF alpha-Function and Control in Colon Cancer$301,056
R01 · FY2005 · CA
Autocrine TGFBeta and Breast Cancer Cell Growth$283,674
R01 · FY2005 · CA
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$416,861
R37 · FY2004 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$346,046
R01 · FY2004 · CA
Autocrine TGFBeta and Breast Cancer Cell Growth$280,239
R01 · FY2004 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$276,221
R01 · FY2004 · CA
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$411,273
R37 · FY2003 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$338,920
R01 · FY2003 · CA
Autocrine TGFBeta and Breast Cancer Cell Growth$276,912
R01 · FY2003 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$269,076
R01 · FY2003 · CA
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$405,848
R37 · FY2002 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$338,323
R01 · FY2002 · CA
Autocrine TGFBeta and Breast Cancer Cell Growth$273,681
R01 · FY2002 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$262,142
R01 · FY2002 · CA
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$400,580
R37 · FY2001 · CA
Autocrine TGFBeta and Breast Cancer Cell Growth$270,544
R01 · FY2001 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$167,585
R01 · FY2001 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$158,138
R01 · FY2001 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$118,886
R01 · FY2001 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$47,262
R01 · FY2001 · CA
HETEROGENEITY OF HUMAN COLON CARCINOMA$267,583
R01 · FY2000 · CA
MECHANISM OF ACTION OF DIFFERENTIATION AGENTS$245,107
R01 · FY2000 · CA
CONTROL OF DIFFERENTIATION IN COLON CARCINOMA$231,019
R01 · FY2000 · CA
AUTOCRINE TGF-A-- FUNCTION AND CONTROL IN COLON CANCER$230,244
R01 · FY2000 · CA
AUTOCRINE TGF B AND BREAST CANCER CELL GROWTH$182,088
R01 · FY2000 · CA